Extent and Risks of Antipsychotic Off-Label Use in Children and Adolescents in Germany Between 2004 and 2011 | Zendy

Carsten Schröder | Zendy; Michael Dörks | Zendy; Bianca Kollhorst | Zendy; Tilo Blenk | Zendy; Regina Dittmann | Zendy; Edeltraut Garbe | Zendy; Oliver Riedel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Extent and Risks of Antipsychotic Off-Label Use in Children and Adolescents in Germany Between 2004 and 2011

Author(s) -

Carsten Schröder,

Michael Dörks,

Bianca Kollhorst,

Tilo Blenk,

Regina Dittmann,

Edeltraut Garbe,

Oliver Riedel

Publication year - 2017

Publication title -

journal of child and adolescent psychopharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.935

H-Index - 84

eISSN - 1557-8992

pISSN - 1044-5463

DOI - 10.1089/cap.2016.0202

Subject(s) - medicine , contraindication , adverse effect , incidence (geometry) , medical prescription , off label use , pediatrics , antipsychotic , psychiatry , schizophrenia (object oriented programming) , pharmacology , alternative medicine , physics , pathology , optics

Only little is known about antipsychotic (AP) off-label use (OLU) in pediatric populations. It was the aim of this study to examine the frequency as well as the risks of off-label AP use in underaged patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research